FindTrial
Sign In

Effect of en bloc nephrectomy for retroperitoneal liposarcoma on post-operative renal function

Effect of en bloc nephrectomy for retroperitoneal liposarcoma on post-operative renal function

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300076349
Enrollment
Unknown
Registered
2023-10-06
Start date
2023-10-06
Completion date
Unknown
Last updated
2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retroperitoneal liposarcomas

Interventions

nephrectomy group:NA
no nephrectomy group:NA

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients aged over 18 who were diagnosed with primary/recurrent retroperitoneal soft tissue sarcoma in West China Hospital of Sichuan University from January 2015 to December 2020 and underwent surgery.

Exclusion criteria

Exclusion criteria: 1. Liposarcoma originating from intestine, kidney, adrenal gland, pancreas, prostate, ovary, uterus and muscle; 2. Surgery or emergency surgery not related to tumor; 3. The pathological diagnosis is not clear; 4. Lost to follow-up during the follow-up period.

Design outcomes

Primary

MeasureTime frame
postoperative acute kidney injury rate (within 7 days after operation);30-day mortality rate;—

Secondary

MeasureTime frame
Length of stay;Length of ICU stay;Overall survival;Disease-free survival;—

Countries

China

Contacts

Public ContactQiang Guo

West China Hospital, Sichuan University

rosebud-1@163.com+86 189 8060 6400

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026